{"id":"W2908094279","doi":"10.1182/blood-2018-184","title":"MURANO Trial Establishes Feasibility of Time-Limited Venetoclax-Rituximab (VenR) Combination Therapy in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Jewish General Hospital","funders":"","keywords":"Venetoclax; Medicine; Bendamustine; Rituximab; Internal medicine; Ven; Gastroenterology; Neutropenia; Minimal residual disease; Refractory (planetary science); Chronic lymphocytic leukemia; Oncology; Leukemia; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001406313,0.0003775631,0.0009508514,0.0004747178,0.0001030114,0.00004505729,0.0004724538,0.0004423328,0.0006078979],"category_scores_gemma":[0.001010119,0.000345354,0.0002434601,0.001053946,0.0006602322,0.000222394,0.0001441162,0.0004436669,0.0002493935],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.07624866,"about_ca_system_score_gemma":0.04728512,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002626372,"about_ca_topic_score_gemma":0.0001800515,"domain_scores_codex":[0.9959424,0.0003698267,0.001003759,0.0007724822,0.001142732,0.0007687925],"domain_scores_gemma":[0.9971533,0.0005363858,0.0003141277,0.001288847,0.0004668114,0.0002405294],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4412533,0.04067173,0.01569514,0.004543801,0.00296478,0.001701571,0.009120254,0.0006894445,0.4068408,0.0008724038,0.007725136,0.06792154],"study_design_scores_gemma":[0.8923743,0.01087013,0.005526171,0.0005178445,0.0001829874,0.0001373573,0.00007053938,0.02359704,0.06512886,0.0003326722,0.0008393713,0.0004226866],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928098,0.001445002,0.000007749216,0.00004807192,0.0003017076,0.002645517,0.00001553328,0.0001379185,0.002588718],"genre_scores_gemma":[0.9977214,0.0003813584,0.0001404311,0.0000812048,0.0005927529,0.0001140097,0.00008383257,0.00007976254,0.0008051953],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.451121,"threshold_uncertainty_score":0.9998999,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03220331108193749,"score_gpt":0.306262982912542,"score_spread":0.2740596718306045,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}